Clabert Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -18.70%
- Profit Growth -14.50%
- Ebitda -0.95%
- Net Worth 1511.51%
- Total Assets 13.37%
About Clabert Lifesciences
Clabert Lifesciences Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2018 (Six years and 11 months 19 days old ). Its registered office is in Chandigarh, Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mahinder Kumar and Gourav Sharma serve as directors at the Company.
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999CH2018PTC041859
- Company No.
041859
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2018
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Clabert Lifesciences Private Limited offer?
Clabert Lifesciences Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Common Disease Medicines, Pharmaceutical Capsules, Antibacterial Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Clabert Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahinder Kumar  | Director | 12-Feb-2018 | Current |
| Gourav Sharma | Additional Director | 12-Jan-2024 | Current |
Financial Performance of Clabert Lifesciences.
Clabert Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.7% decrease. The company also saw a substantial fall in profitability, with a 14.5% decrease in profit. The company's net worth Soared by an impressive increase of 1511.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clabert Lifesciences?
Unlock access to Clabert Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clabert Lifesciences?
Unlock and access historical data on people associated with Clabert Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clabert Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clabert Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
